Michael Young

Keynote Lecture by

Erin K. O’Shea

Vice President and Chief Scientific Officer
Howard Hughes Medical Institute


Paul C. Mangelsdorf Professor of Molecular and Cellular Biology
and of Chemistry and Chemical Biology

Harvard University


Erin O'Shea's lab focuses on (1) understanding how gene regulatory networks encode and decode information to control gene expression and (2) investigating the function and mechanism of oscillation of a three-protein circadian clock. In a new project, she is studying the mechanism of drug action, making use of a human cell line amenable to loss-of-function genetic approaches.


Dr. O'Shea is a professor of chemistry and chemical biology, and director of the Harvard FAS Center for Systems Biology at Harvard University. She was an HHMI investigator from 2000 to 2013. In July 2013, she became HHMI vice president and chief scientific officer.